Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Valneva SE
  6. News
  7. Summary
    VLA   FR0004056851

VALNEVA SE

(VLA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about VALNEVA SE
01/20Valneva Gains 20% as COVID-19 Jab Shows Effect Against Omicron in Preliminary Studies
MT
01/20VALNEVA : Kepler Cheuvreux reiterates its Buy rating
MD
01/19Valneva COVID-19 Jab Shows Effect Against Omicron After Three Doses in Phase 1/2 Study
MT
01/19Valneva's Vaccine Candidate Neutralizes Omicron Variant in Early Studies; Shares Surge
MT
01/19VALNEVA : Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant - For..
PU
01/19Latest on the worldwide spread of the coronavirus
RE
01/19Valneva says early studies show COVID-19 vaccine effective against Omicron
RE
01/19Valneva says early studies show COVID-19 vaccine effective against Omicron
RE
01/19Valneva's Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant
AQ
01/19Valneva SE Announces Results from an Initial Laboratory Study Demonstrating That Serum ..
CI
01/19Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
01/18Valneva Slips 5% As EU Drug Regulator Awaits Additional Data On COVID-19 Vaccine Candid..
MT
01/18Valneva shares dip after EU regulator comments on status of covid-19 vaccine approval
RE
01/10VALNEVA : Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated ..
PU
01/10Valneva SE Confirms Clinical Trial and Regulatory Submission Timelines for Its Inactiva..
CI
More most relevant news
All news about VALNEVA SE
01/20Top Premarket Decliners
MT
01/20EUROPEAN MIDDAY BRIEFING - Stocks Down After Mixed Asia Trading, US Fall
DJ
01/20Valneva Gains 20% as COVID-19 Jab Shows Effect Against Omicron in Preliminary Studies
MT
01/20VALNEVA : Kepler Cheuvreux reiterates its Buy rating
MD
01/19Valneva COVID-19 Jab Shows Effect Against Omicron After Three Doses in Phase 1/2 Study
MT
01/19Valneva's Vaccine Candidate Neutralizes Omicron Variant in Early Studies; Shares Surge
MT
01/19VALNEVA : Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant - For..
PU
01/19Latest on the worldwide spread of the coronavirus
RE
01/19Valneva says early studies show COVID-19 vaccine effective against Omicron
RE
01/19Valneva says early studies show COVID-19 vaccine effective against Omicron
RE
More news
News in other languages on VALNEVA SE
01/21VALNEVA : parmi les plus fortes baisses du SRD à la clôture du vendredi 21 janvier 2022
01/20L'Europe finit dans le vert, les résultats des sociétés en soutien
01/20Paris finit dans le vert une séance sans tendance marquée
01/20MÄRKTE EUROPA/Erneut aufwärts - Geschäft bei Puma läuft gut
01/20AKTIEN EUROPA SCHLUSS : US-Börsen schieben die Kurse an
01/20CAC40 : se rapproche des 7.200, Wall Street dans le vert
01/20VALNEVA : plus forte hausse du SRD à la clôture du jeudi 20 janvier 2022
01/20VALNEVA : plus forte hausse du SBF 120 à la clôture du jeudi 20 janvier 2022
01/20Aktien Schweiz drehen ins Plus
01/20CAC40 : retrouve le vert et flirte avec les 7.200 points
More news
Analyst Recommendations on VALNEVA SE
01/20VALNEVA : Kepler Cheuvreux reiterates its Buy rating
MD
2021VALNEVA : Guggenheim Starts Valneva SE at Buy With $36 Price Target
MT
2021VALNEVA : Jefferies Initiates Valneva SE at Buy With $36 Price Target
MT
2021ANALYST RECOMMENDATIONS : Domino's Pizza, easyJet, McDonald's, Boeing, Yum! Brands....
2021VALNEVA : Goldman Sachs Starts Valneva SE at Buy With $34 Price Target
MT
More recommendations
Press releases
01/19VALNEVA : Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant - For..
PU
01/19Valneva's Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant
AQ
01/10VALNEVA : Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated ..
PU
01/06Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated..
AQ
2021VALNEVA : Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chik..
PU
More press releases
Upcoming event on VALNEVA SE